HK1030155A1 - Treatment of scar tissue using lipoic acid - Google Patents

Treatment of scar tissue using lipoic acid

Info

Publication number
HK1030155A1
HK1030155A1 HK01101133A HK01101133A HK1030155A1 HK 1030155 A1 HK1030155 A1 HK 1030155A1 HK 01101133 A HK01101133 A HK 01101133A HK 01101133 A HK01101133 A HK 01101133A HK 1030155 A1 HK1030155 A1 HK 1030155A1
Authority
HK
Hong Kong
Prior art keywords
acid
lipoic
scar tissue
dihydrolipoic
lipoic acid
Prior art date
Application number
HK01101133A
Other languages
English (en)
Inventor
Nicholas V Perricone
Original Assignee
Nicholas V Perricone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas V Perricone filed Critical Nicholas V Perricone
Publication of HK1030155A1 publication Critical patent/HK1030155A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK01101133A 1997-11-17 2001-02-16 Treatment of scar tissue using lipoic acid HK1030155A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/971,820 US5965618A (en) 1997-11-17 1997-11-17 Treatment of scar tissue using lipoic acid
PCT/US1998/024514 WO1999025330A1 (en) 1997-11-17 1998-11-16 Treatment of scar tissue using lipoic acid

Publications (1)

Publication Number Publication Date
HK1030155A1 true HK1030155A1 (en) 2001-04-27

Family

ID=25518838

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01101133A HK1030155A1 (en) 1997-11-17 2001-02-16 Treatment of scar tissue using lipoic acid

Country Status (9)

Country Link
US (1) US5965618A (xx)
EP (1) EP1039891B1 (xx)
JP (1) JP4027593B2 (xx)
AT (1) ATE301996T1 (xx)
CA (1) CA2309717C (xx)
DE (1) DE69831269T2 (xx)
ES (1) ES2247728T3 (xx)
HK (1) HK1030155A1 (xx)
WO (1) WO1999025330A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701264A1 (de) * 1997-01-16 1998-07-23 Kief Lizenz Verwertungsgesells Heilmittel, enthaltend Betasitosterin und/oder Phytosterol/Betasitosteringemische
US6365623B1 (en) 1997-11-17 2002-04-02 Nicholas V. Perricone Treatment of acne using lipoic acid
FR2793681B1 (fr) * 1999-05-18 2001-06-22 Oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
US6288106B1 (en) * 1999-05-25 2001-09-11 Chronorx, Llc Processes for the synthesis and use of various α-lipoic acid complexes
US6572878B1 (en) * 2000-09-07 2003-06-03 Robert Blaine Method and device for treating scars
US7285284B2 (en) * 2000-09-08 2007-10-23 Kuhnau Stephen C Cosmetic composition, method of use and method of making
IT1319195B1 (it) * 2000-10-10 2003-09-26 Laboratorio Chimico Int Spa Processo per la produzione dell'acido r(+)alfa-lipoico.
US6743433B2 (en) 2001-07-06 2004-06-01 Nicholas V. Perricone Treatment of acne using alkanolamine compositions
US6908941B2 (en) * 2002-06-06 2005-06-21 Nicholas V. Perricone Hair and nail treatments using alkanolamines
TR200301291A2 (tr) * 2002-08-20 2004-02-23 Dart Industries Inc. Şekil verilmiş gıda maddelerinin oluşturulması için ayarlanabilir kalıp
US7306810B1 (en) 2002-11-25 2007-12-11 Piedmont Cosmeceuticals, Inc. Skin cream
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
JP2005104920A (ja) * 2003-09-30 2005-04-21 Ya Man Ltd 皮膚外用剤及びその使用方法
US20050192229A1 (en) * 2004-02-27 2005-09-01 Perricone Nicholas V. Topical glutathione treatments
GB0426255D0 (en) * 2004-11-30 2004-12-29 Younger Skin Ltd Improvements in and relating to products for skin treatment
ITPD20050168A1 (it) * 2005-06-01 2006-12-02 Fidia Advanced Biopolymers Srl Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
US20070225354A1 (en) * 2006-03-21 2007-09-27 Eric Marchewitz Use of dihydrolipoamide for enhancing physical performance
EP2252690A2 (en) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
JP2011507860A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
CN102245765B (zh) * 2008-10-21 2015-01-07 通用医院公司 细胞移植
US9199102B2 (en) 2009-07-21 2015-12-01 Oradin Pharmaceutical Ltd. A3 adenosine receptor ligands for modulation of pigmentation
WO2011152832A1 (en) 2010-06-04 2011-12-08 N.V. Perricone Llc Methods of use of nitroalkene compositions in dermatologic applications to prevent or treat skin aging
WO2012006107A2 (en) 2010-06-28 2012-01-12 Stemtide, Inc. Skin care compositions
EP3530741B1 (en) 2010-08-06 2021-04-07 The General Hospital Corporation D/B/A Massachusetts General Hospital System and apparatus for cell treatment
EP2446905B1 (en) 2010-10-29 2019-10-02 Aesculap AG Medical device having anti-scarring properties
US9034926B2 (en) 2010-12-30 2015-05-19 Nicholas V. Perricone Topical nitrone spin trap compositions for psoriasis
US9421234B2 (en) * 2011-05-20 2016-08-23 Nutramax Laboratories, Inc. Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
WO2013091894A2 (en) 2011-12-21 2013-06-27 Flavin Dana Topical compositions
ES2700983T3 (es) * 2012-06-08 2019-02-20 Univ Ohio State Tratamiento de lesión cicatricial usando tocotrienol
CN107789660A (zh) * 2016-08-31 2018-03-13 杜建 一种用于皮肤及软组织损伤的医用敷料

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
JPH03169813A (ja) * 1989-11-09 1991-07-23 Asta Pharma Ag 細胞保護作用を有する疼痛及び炎症性疾患及び／又はレトロウイルスに起因する病気の治療用医薬並びにその製法
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
DE4313428A1 (de) * 1992-01-18 1994-10-27 Margarethe Rabien Kombinationspatent in dem alpha-Liponsäure + Pantothensäure (bzw. Dexpanthenol) vorkommen gegen Entzündungen, Hautkrankheiten entzündlicher + allergischer Natur, schlecht heilende Wunden
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
DE4345199C2 (de) * 1993-05-22 1995-10-12 Asta Medica Ag Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
DE4343593C2 (de) * 1993-12-21 1998-05-20 Asta Medica Ag Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz
US5444091A (en) * 1994-05-24 1995-08-22 Dermatology Home Products, Inc. Method of applying alpha hydroxy acids for treating striae distensae
JPH10501817A (ja) * 1994-06-15 1998-02-17 ザ、プロクター、エンド、ギャンブル、カンパニー 哺乳動物皮膚における色素過剰部位のライトニング方法
US5472698A (en) * 1994-12-20 1995-12-05 Elizabeth Arden Co., Division Of Conopco, Inc. Composition for enhancing lipid production in skin
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
AU6436998A (en) * 1997-02-20 1998-09-09 Yale University Therapeutic uses for antioxidants

Also Published As

Publication number Publication date
CA2309717A1 (en) 1999-05-27
DE69831269T2 (de) 2006-03-30
DE69831269D1 (de) 2005-09-22
ES2247728T3 (es) 2006-03-01
CA2309717C (en) 2004-01-06
JP2001522878A (ja) 2001-11-20
WO1999025330A1 (en) 1999-05-27
EP1039891A4 (en) 2003-06-11
JP4027593B2 (ja) 2007-12-26
EP1039891B1 (en) 2005-08-17
EP1039891A1 (en) 2000-10-04
ATE301996T1 (de) 2005-09-15
US5965618A (en) 1999-10-12

Similar Documents

Publication Publication Date Title
HK1030155A1 (en) Treatment of scar tissue using lipoic acid
ES2129013A1 (es) Utilizacion de la vitamina c o de sus derivados o analogos para estimular la sintesis de la elastina cutanea.
CA2232583A1 (en) Lipoic acid in topical compositions
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
ATE197116T1 (de) Verbesserte zusammensetzung mit andauerndem energetischem und anabolem effekt
DE69325450D1 (de) Potenzierung von antimikrobiellen wirkungen
KR950031034A (ko) 화장품 또는 피부과용 조성물 및 그의 제법
AU3460389A (en) Non-aqueous compositions containing pyroglutamic acid esters for topical application to human skin or hair
ATE359767T1 (de) Pflaster zur äusserlichen anwendung
ES2085192A1 (es) Composiciones cosmeticas despigmentantes a base de acido cafeico.
WO2001026606A2 (en) Treatment of scar tissue using lipoic acid
BR9810121A (pt) Utilização do acido petroselìnico nativo ou esterificado
AU2003228854A1 (en) Stabilized antiperspirant compositions containing aluminum-zirconium salts with low m:cl ratio -
WO2001049250A3 (en) Treatment of acne using lipoic acid
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
DE68913476D1 (de) Kosmetisches Präparat.
ATE406154T1 (de) Zusammensetzung enthaltend ozonisierte öle und/oder andere natürliche und/oder synthetische ozonizierte produkte und ihre verwendung in pharmazeutischen, kosmetischen, diätetischen oder nahrungsergänzenden zusammensetzungen in human- und veterinärgebieten
ES2124395T3 (es) Utilizacion de esteres de diglicerina contra las impurezas de la piel.
ATE238805T1 (de) Multifunktionelle formulierung für fettabsorbierung und zur senkung des cholesterolgehaltes im blut, welche chitosan und nicotinsäure enthält
EP0381057A3 (en) Chemical composition for external application
JPS567776A (en) Diesterified compound of kojic acid
KR910000102A (ko) 효소형성 억제제
KR890701098A (ko) 히드로퀴논 및 코지산을 함유하는 제약 또는 화장제 조성물
EP0347932A3 (en) Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
CA2385301A1 (en) Peeling composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151116